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NaIH antiport is one of the primary mechanisms involved in
the extrusion of H from vertebrate cells. Originally described by
Murer, Hopfer and Kinne [1] in vesicles from brush border
membranes of kidney tubules, the presence of the transporter has
been, since that time, identified in the plasma membrane of
virtually all eukaryotic cells. Biochemical studies initially and
more recently molecular cloning have provided increasing amount
of information about the structure, functional features and regu-
lation of the Na/H exchangers, referred to as NHE, [reviewed
in 2, 3]. Na/H exchangers are integral plasma membrane
proteins which catalyze the electroneutral exchange of extracellu-
lar Na for intracellular H with a stoichiometry of one for one.
An essential feature of these exchangers is their allosteric activa-
tion by intracellular protons, which are presumed to interact at a
"modifier" site that is separate from the sites involved in Na and
H transport. The activity and expression level of the exchangers
can be modulated by a remarkably wide variety of stimuli includ-
ing growth factors, tumor promoters, hormones [reviewed in 4],
chronic extracellular acidification [5], as well as physical factors
such as changes in cell volume [6], or cell spreading [7]. The most
widely studied NHE isoform, NHE1, is ubiquitously expressed
and is involved in a variety of cellular functions by virtue of its
ability to govern intracellular pH. It is inhibited by the diuretic
compound amiloride and its 5-amino substituted derivatives.
Besides NHE1, several other isoforms—initially characterized by
their lower sensitivity to amiloride—have been identified princi-
pally in epithelia where they perform more specialized ion
transport. Five subtypes of Na/H exchangers have been cloned
and characterized to date, they share the same structure and
define a new gene family of vertebrate transporters.
In this manuscript, we will give an overview of the main features
of the NattH± exchanger isoform NHE1 with emphasis on recent
progress in understanding the structure-function relationship and
the mechanisms of regulation of this isoform.
Molecular identification of the Na/H exchangers
Using a genetic strategy, Sardet, Franchi and Pouysségur [8]
were the first to fully identify a Na/H exchanger isoform by
cloning a human cDNA encoding the amiloride-sensitive, growth
factor-activatable Na /H + antiporter. This cDNA, cloned by
functional complementation of a Na/H antiport-deficient cell
line was shown to fully restore the biochemical and physiological
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features of the transporter, namely amiloride-sensitive pH, regu-
lation, when transfected in antiporter-deficient cells. This human
exchanger cDNA, now referred to as NHE1, is ubiquitously
expressed in tissues and cells and, in polarized epithelial cells,
generally resides in the basolateral membrane although excep-
tions have been reported (Noel J, Roux D, and Pouysségur J,
manuscript submitted). Pharmacological, kinetic and regulatory
properties of Na/H exchangers in various cell types, tissues and
species had predicted the existence of multiple isoforms of
Na7Ii exchangers [reviewed in 9]. Recent molecular cloning
studies have confirmed that indeed Na/H exchangers constitute
a gene family from which so far five vertebrate isoforms: NHE1,
f3NHE, NHE2, NHE3, and NHE4 have been cloned and se-
quenced [reviewed in 3].
Structural features
Based on their hydropathy profiles, Na/H exchangers exhibit
similar topologies: the molecule has two separate functional
domains: a N-terminal hydrophobic domain (made up of 10 to 12
membrane spanning segments) with approximately 500 amino
acids and the C-terminal hydrophilic domain with 300 amino
acids.
The isoforms of Nat1H exchangers cloned so far are homol-
ogous [reviewed in 2, 3]. NHE1, NHE2, NHE3 and NHE4 share
40 to 60% overall amino acid identity. The membrane spanning
domains constitute the most highly conserved portions of the
molecule and exhibit 50 to 60% amino acid identity. It is
noteworthy that among them, the two segments, M5a and M5b,
appear to be almost identical in all the cloned isoforms, suggesting
that this part of the exchanger should play a crucial role in the
structure of the molecule and/or in the ion transport mechanism.
In addition, all the isoforms possess a first putative transmem-
brane segment which displays the features of a cleavable signal
peptide [10]. The cytoplasmic domains share only 30 to 40%
homology; all of them contain variable putative protein kinase
consensus sequences. The NHE isoform, cloned from trout red
blood cells, exhibits a large degree of homology with NHE1: 74%
homology for the transmembrane domain and 48% for the
cytoplasmic domain [11].
Glycosylation
NHE1 is glycosylated. The NHE1 sequence possesses three
consensus sites for N-linked glycosylation at asparagine residues
75, 370 and 410. Indeed, treatment of NHE1 with endoglycosidase
F was found to reduce the apparent size of NHE1 from 110 to 90
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kDa, indicating that NHEI is a glycoprotein [12]. To analyze the
potential functional conscqucnces of deglycosylation, site-di-
rected mutagenesis at the individual N-glycosylation consensus
sites (Asn to Asp) was performed and the cDNAs containing
combinations of these three mutations generated. Expression of
the mutated cDNAs in antiporter-deficient PSI2O fibroblasts
showed that all constructs produced functional transporters that
had transport rates and pharmacological profiles similar to the
wild type molecule, indicating that N-linked glycosylation of
NHEI is completely dispensable for its expression and function.
in addition, this study demonstrated that: (i) only the first
N-glycosylation site (Asn 75) is used, and (ii) this extracellular
domain of NHE1 possesses multiple sites of 0-glycosylation [10].
Dimerization
NHEI and NHE3 form stable homodimers in intact cells. A
recent study [131 demonstrated that, like many other transporters,
both NHE1 and NHE3 exist as stable dimers in the membrane
suggesting that oligomerization might be a common feature of
Na1H exchange transporters. Importantly for membrane sort-
ing, coexpression of NHE1 and NHE3 in the same cells did not
lead to the formation of heterodimers demonstrating an isoform
specificity for the subunit interaction. In addition, this study
showed that, despite the formation of oligomers as the basic
structural unit, the monomer seems to represent the minimal
functional unit for NHE1. However, further work is required
before a definitive conclusion could be attained.
Identification of distinct functional domains
To study the structure-function relationship of the Na/H
antiporter, Wakabayashi et al [14] generated a set of eDNA
deletion mutants within the C-terminal cytoplasmic domain of the
human NHE1 and expressed them in the antiporter-defieient
fibroblast cell line PS12O. This study led to the following impor-
tant conclusions. Deletion of the entire cytoplasmic domain: (i)
preserves amiloride-sensitive Na/H exchange activity, indicat-
ing that the N-terminal domain is sufficient both for insertion of
the exchanger into the plasma membrane and to carry out the
transport; (ii) markedly shifts the pK value for intracellular H to
the acidic range but preserves the allosteric activation of the
exchanger by the internal H, indicating that the H modifier site
must be located within the N-terminal domain; (iii) abolishes
growth factor-induced eytosolie alkalinization, demonstrating that
the cytoplasmic domain is crucial for mediating extracellular
signals; (iv) does not prevent the formation of homodimers,
indicating that the transmembrane domain is sufficient for dimer-
ization [13]. From these studies a model can be extrapolated
where the antiporter can be separated into two distinct functional
domains: the NH2 terminal transmembrane domain, which pos-
sesses all the information to catalyze the ion exchange, and the
cytoplasmie C-terminal domain, which determines the pH set
point of the exchanger and mediates the activation of the ex-
change by growth factors. Consistent with this functional model, a
study on the trout red cell exchanger J3NHE, that is activated by
cAMP, demonstrated that deletion of the C-terminal region of the
cytoplasmic loop containing the cAMP-dependent consensus sites
preserves both the ability of the exchanger to catalyze amiloride-
sensitive Nat /}j exchange activity and the characteristics of the
H modifier site, while abolishing activation by cAMP [11]. More
importantly, grafting the cytoplasmic domain of f3NHE to the
human NHE1 N-terminal domain confers cAMP-sensitivity to the
human NHE1 chimera [15] These results demonstrate that the
cytoplasmic domain dictates the nature of the hormonal regula-
tion within the NHE family.
Molecular mechanism of activation
Protein kinases appear to play a predominant role in the
regulation of the Na/Ht exchangers but the mechanisms of
regulation at a molecular level are not yet fully elucidated. Most
mitogens activate the NHE1 isoform leading to an intracellular
alkalinization [reviewed in 4] mostly detectable in the absence of
bicarbonate [16, 17]. At least three groups have reported that
mitogenic agents activate the antiporter by shifting the pH-
dependence of the modifier site, adjusting the set point upward by
0.15 to 0.30 pH units, which is the magnitude of the alkalosis
recorded in most cases [18—21]. As a result, the exchanger is
activated, but only temporarily, returning to near quiescence when
pH attains the new set point value. It had been repeatedly
speculated that the alteration in the set point was mediated by
phosphorylation of the antiporter itself or of an ancillary protein.
This speculation was based on the following observations: first,
the biological effects of most, if not all, of the mitogens known to
activate the antiporter are believed to be mediated by protein
kinases; second, in the case where the metabolic dependence of
the response was studied [22, 23], the stimulation of the antiporter
was shown to depend on the availability of cellular ATP, the
substrate of the putative kinases; thirdly, in the cases of agents
thought to act via stimulation of protein kinase C, depletion of
this enzyme prior to addition of the stimulus precluded the
activation of the antiport [24, 25]. Finally, immunoprecipitation of
NHEI in 32P-labeled fibroblasts demonstrated that "resting"
NHE1 is phosphorylated and that mitogenic stimulation is accom-
panied by an increase in phosphorylation of NHE1, with a time
course similar to the rise in intracellular pH [12]. Moreover,
okadaic acid, a serine/threonine protein phosphatase inhibitor can
by itself trigger activation of NHEI in correlation with stimulation
of its phosphorylation [23, 26]. Based on these results, phosphor-
ylation of NHE1 has been hypothesized to trigger directly the
activation of the antiporter. Phosphorylation of NHE1 was dem-
onstrated to occur exclusively on serine residues whatever the
stimulus used [12]. This is the case for stimulation by EGF and
thrombin which are known to activate distinct transmembrane
signalling pathways (receptor tyrosine kinase in the case of EGF;
O protein-coupled activation of phospholipase C, followed by
stimulation of protein kinase C for thrombin). Moreover, tryptic
phosphopeptide maps of NHEI immunoprecipitated from cells
treated with EOF or thrombin showed a common pattern of
phosphorylation [26]. These results suggest that the various
signals activating NHE1 converge to a common pathway leading
to activation of a putative NHE1 kinase. The mitogen-activated
protein (MAP) kinase pathway that has been shown to be
essential for the propagation of growth factors signals [27] is a
good candidate for NHE1 kinase activation. Consistent with this
hypothesis, we found that expression of a p44 MAP kinase
dominant negative mutant partially inhibited the growth factor
stimulation of NHE1 (0. L'Allemain and J. Pouysségur, unpub-
lished observations).
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Recent evidence, however, shows that phosphorylation of
NHEI cannot fully account for its activation. Using a set of
deletion and point mutants, Wakabayashi et al [281 showed that
while the cytoplasmic region between amino acid 567 and 635 is
crucial for high pH1 sensitivity and growth factor activation, all
major phosphorylation sites are located in the most distal part of
the cytoplasmic tail between amino acid 636 and 815. Deletion of
this 636 to 815 region was shown to preserve part of the growth
factor response, supporting the existence of an additional mech-
anism not requiring direct phosphorylation of the antiporter for
mediating growth factor signal. The simplest hypothesis to ac-
count for these results is to postulate the existence of one or
multiple regulatoiy protein(s) which would control NHE1 activa-
tion through interaction with its cytoplasmic domain. This regu-
latory protein could itself be subjected to phosphorylation in
response to growth factors. It is noteworthy that the existence of
an alternative mode of activation of the antiporter not requiring
its direct phosphorylation had been previously postulated by
Grinstein et al [29] in the context of their study of the activation
of NHE1 during volume regulation. Like growth factors, hyper-
osmotic stress has been shown to activate the antiporter by
increasing its sensitivity to intracellular H [22]; however, the shift
in pH sensitivity induced by the osmotic shock is not associated
with increased phosphorylation of the exchanger. Identification of
putative regulatory proteins interacting with NHE1 is pursued in
our group by P. Fafournoux exploiting the yeast two-hybrid
system. Several cDNA clones encoding proteins that specifically
interact with the cytoplasmic domain of NHE1 have been isolated
and are currently under investigation.
Very recently, a study by Bertrand et a! permitted a greater
insight into the mechanism of NHE1 activation. By studying the
direct interaction of calmodulin with NHE1, they identified and
characterized two Ca2/calmodulin-binding sites located in the
middle of the cytoplasmic regulatory domain of NHE1 [30]. They
demonstrated that deletion of the high affinity calmodulin-binding
region (residues 636 to 656) and point mutations of positively
charged residues within this region reduced the cytoplasmic
alkalinization in response to growth factors and hyperosmotic
stress with a concomitant loss of the calmodulin-binding ability,
suggesting that binding of Ca2/calmodulin to the high affinity
calmodulin-binding region is involved in the activation of NHE1
in response to extracellular signals. In addition, the authors
showed that mutations that prevented calmodulin-binding to this
high affinity region rendered NHE1 constitutively active by induc-
ing an alkaline shift in the pH1-dependence of NHE1 [31]. These
results therefore indicate a model where calmodulin-binding
region 636 to 656 functions as an autoinhibitory domain for NHE1
and Ca21calmodulin activates NHE1 by binding to this region
and thus abolishing its inhibitory effect.
NHE1 activation has also been reported to occur upon cell
spreading on dishes coated with fibronectin [7]. These effects are
likely to be mediated by extracellular matrix proteins such as
fibronectin and their receptors the integrins. Integrins are known
to anchor microfilaments to the membrane through a direct
interaction with talin and a-actinin and to a set of cytoskeletal
proteins such as vinculin, paxillin, zyxin, and actin [32]. In this
context, it is noteworthy that NHE1 was found to be enriched
together with F-actin, vinculin and talin [33], suggesting some
interaction—direct or indirect—between NHE1 and cytoskeletal
elements.
Concluding remarks
Identification of the primary structure of the Na17H exchang-
ers by cloning their cDNAs represented a major advance in the
biology of these wide spread transporters. The picture of the
regulation of these exchangers, although in constant progress is
still far from complete. In the case of the ubiquitous isoform
NHE1: activation in response to growth factors appears to be
controlled by at least three different mechanisms: (1) the effect of
(a) regulatory protein(s) interacting with the cytoplasmic domain
of NHE1, which is potentially phosphotylated; (2) elevation of
[Ca2]1, leading to the binding of Ca21calmodulin complex to the
high affinity calmodulin-binding domain (636—656), (3) direct
phosphorylation of the cytoplasmic domain of NHE1, occurring
downstream of the 635 amino acid residue, by NHE1 kinase.
Identification of the phosphorylation sites involved in NHE1
activation by growth factors is pursued in our group: the localiza-
tion of the serine residues involved in the growth factors response
followed by the mutation of the residues identified as potential
phosphorylation sites should allow to elucidate the contribution of
direct phosphorylation of NHE1 in the response to growth factors.
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